AMLX — AMYLYX PHARMACEUTICALS INC
As of Q2 2026, 31 SEC-registered investment managers reported holding AMLX (AMYLYX PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $804.54M across 44.86M shares. That is -4.8% by share count (-2.24M shares) versus the previous quarter, while reported value moved +23.2%. Ownership is concentrated: the five largest holders account for 77.0% of reported value and the top ten for 91.9%.
Compared with the prior quarter, 3 opened new positions, 16 added to existing stakes, 10 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
AMLX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 16.73M | $300.43M | 0.01% | Add |
| BlackRock Inc history | Q2 2026 | 8.83M | $158.53M | 0.00% | Hold |
| Vanguard Group history | Q4 2025 | 5.80M | $70.12M | 0.00% | Add |
| Janus Henderson Group history | Q1 2026 | 4.99M | $69.26M | 0.03% | Add |
| Morgan Stanley history | Q2 2026 | 3.13M | $56.23M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 2.95M | $52.99M | 0.01% | Add |
| Goldman Sachs Group history | Q2 2026 | 2.86M | $51.33M | 0.01% | Add |
| Viking Global Investors history | Q4 2023 | 2.96M | $43.61M | 0.16% | Hold |
| Geode Capital Management history | Q2 2026 | 2.34M | $41.95M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 1.86M | $34.92M | 0.00% | New |
| Northern Trust Corp history | Q2 2026 | 831.74K | $14.94M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 821.84K | $14.76M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 725.03K | $13.02M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 684.97K | $12.30M | 0.02% | Reduce |
| Two Sigma Investments history | Q2 2026 | 593.43K | $10.66M | 0.01% | Add |
| Deutsche Bank AG history | Q2 2026 | 557.94K | $10.02M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 274.44K | $4.93M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 271.88K | $4.88M | 0.00% | Reduce |
| Wellington Management Group history | Q2 2026 | 212.84K | $3.82M | 0.00% | Reduce |
| Farallon Capital Management history | Q3 2024 | 1.15M | $3.73M | 0.02% | Hold |
New Positions (Q2 2026)
- JPMorgan Chase & Co 1.86M sh · $34.92M
- Norges Bank Investment Management 159.90K sh · $2.87M
- CPP Investments 27.60K sh · $495.70K
Fully Exited (vs previous quarter)
- Janus Henderson Group sold 4.99M sh · $69.26M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 88.12K | 122.44K | 336 | 7.80K | 7.23K | 448.98K | 438.69K | 1.44M | 19.39K | 56.38K | 221.00K | 731.36K | 1.16M | 3.05M | 11.38M | 16.52M | 16.63M | 16.73M |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | 2.55M | 2.28M | 2.39M | 5.51M | 7.14M | 9.05M | 8.83M | 8.83M |
| Morgan Stanley | 42.34K | 43.11K | 269.07K | 484.47K | 902.55K | 1.05M | 952.12K | 2.83M | 2.07M | 924.46K | 478.26K | 464.22K | 474.42K | 486.89K | 1.95M | 2.36M | 2.18M | 3.13M |
| Franklin Resources | — | — | — | — | — | 28.49K | 617.87K | 1.33M | 1.86M | — | — | — | — | — | — | 1.20M | 2.26M | 2.95M |
| Goldman Sachs Group | — | — | 379.40K | 1.04M | 1.37M | 1.35M | 1.19M | 1.26M | 2.94M | 2.61M | 1.61M | 1.86M | 2.00M | 1.30M | 2.01M | 2.61M | 2.63M | 2.86M |
| Geode Capital Management | 190.15K | 231.42K | 635.56K | 853.91K | 890.98K | 938.00K | 982.07K | 1.03M | 1.07M | 468.87K | 551.04K | 567.90K | 806.16K | 1.69M | 1.81M | 2.17M | 2.21M | 2.34M |
| JPMorgan Chase & Co | 4.50K | 6.13K | 19.26K | 49.70K | 43.60K | 190.30K | 90.97K | 8.30K | 409.76K | 57.51K | 140.56K | 55.61K | 54.07K | 87.99K | 35.84K | 66.55K | — | 1.86M |
| Northern Trust Corp | 82.17K | 94.54K | 285.81K | 395.14K | 463.88K | 485.42K | 425.78K | 435.44K | 425.57K | 367.25K | 95.35K | 106.56K | 139.33K | 820.16K | 822.24K | 937.76K | 779.91K | 831.74K |
| Bank of America Corp | 2.90K | 16.57K | 8.89K | 63.37K | 68.32K | 117.21K | 78.19K | 120.33K | 275.96K | 477.52K | 912.51K | 2.43M | 794.35K | 451.81K | 429.52K | 1.34M | 1.33M | 821.84K |
| Charles Schwab Investment Management | 73.03K | 70.41K | 240.74K | 317.72K | 320.09K | 325.48K | 365.86K | 387.62K | 435.90K | 521.62K | 302.27K | 298.95K | 372.85K | 588.41K | 645.18K | 712.99K | 716.23K | 725.03K |
| Balyasny Asset Management | 62.91K | — | 191.33K | 645.55K | 420.84K | 1.60M | 696.88K | 19.70K | — | 22.89K | 50.90K | 50.25K | 148.56K | — | 1.48M | 858.68K | 1.11M | 684.97K |
| Two Sigma Investments | — | — | — | — | — | — | — | 43.80K | 1.43M | 1.30M | 367.24K | 651.52K | 762.05K | 558.85K | 98.42K | 344.40K | 161.94K | 593.43K |
| Deutsche Bank AG | 5.35K | 4.69K | 14.98K | 21.96K | 31.32K | 191.61K | 24.42K | 853.00K | 756.17K | 570.86K | 570.86K | 570.86K | 570.86K | 616.92K | 1.37M | 1.33M | 1.27M | 557.94K |
| BNY Mellon | 26.45K | 29.02K | 116.94K | 210.14K | 204.66K | 163.88K | 163.59K | 191.00K | 198.03K | — | 23.68K | — | — | 150.84K | 182.96K | 217.35K | 251.10K | 274.44K |
| UBS Group AG | 4.16K | 177 | 133.99K | 31.38K | 130.05K | 101.97K | 4.61K | 39.01K | 210.57K | 30.14K | 229.08K | 643.52K | 1.39M | 1.25M | 1.40M | 543.32K | 324.32K | 271.88K |
| Wellington Management Group | — | — | — | 67.91K | 108.43K | 17.72K | — | 44.75K | 33.93K | — | — | 209.71K | 290.68K | 288.62K | 236.20K | 225.78K | 241.55K | 212.84K |
| Citadel Advisors | 501.64K | 1.08M | 1.46M | 196.96K | 425.51K | 1.03M | 1.48M | 2.60M | 2.26M | 1.55M | 2.15M | 2.23M | 2.82M | 1.29M | 371.77K | 456.87K | 469.63K | 189.39K |
| D. E. Shaw & Co | — | — | 162.26K | 1.38M | 2.02M | 1.59M | 760.29K | 546.97K | 1.04M | 1.31M | 691.07K | 306.74K | 270.01K | 151.50K | 68.88K | 73.22K | 74.23K | 174.28K |
| Norges Bank Investment Management | — | — | — | 81.20K | — | — | — | 116.40K | — | — | — | — | — | — | — | — | — | 159.90K |
| Invesco Ltd | — | — | 261.54K | 215.47K | 22.94K | 26.74K | 29.84K | 23.89K | 24.35K | — | — | — | 45.69K | 586.88K | 810.64K | 175.91K | 171.62K | 139.94K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details